Disease
22 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 7, 2026 · JOURNAL ARTICLE
International Journal of Medical & Pharmaceutical Sciences
A narrative review synthesizing evidence from pivotal trials to evaluate GLP-1 receptor agonists for weight management, offering clinical recommendations rather than reporting original research.
SEP 7, 2026 · JOURNAL ARTICLE
Frontiers in Endocrinology
A narrative review synthesising current understanding of obesity management across non-pharmacological, herbal, approved pharmacological and emerging therapeutic strategies, without presenting new primary data or systematic evidence synthesis.
SEP 7, 2026 · JOURNAL ARTICLE
International Journal of Medical & Pharmaceutical Sciences
A narrative review synthesizing evidence from pivotal trials to provide clinical recommendations on GLP-1 agonist use for weight management, addressing efficacy, safety and individualized patient selection.
SEP 7, 2026 · JOURNAL ARTICLE
Journal of Integrative and Translational Biomedicine
In vitro cell culture study showing mechanistic effects on lipid metabolism without clinical outcomes, efficacy data, or in vivo validation; raises questions about therapeutic potential rather than answering them.
SEP 6, 2026 · REVIEW
Obesity Science & Practice
Rigorous meta-analysis of 19 randomized trials using GRADE methodology and Cochrane risk-of-bias assessment, revealing a substantial discrepancy between reported and objective nutritional markers that should inform clinical monitoring practice.
SEP 6, 2026 · JOURNAL ARTICLE
Andrology and Genital Surgery
A single-centre cross-sectional study with modest sample size and no control group for adipokine differences; correlational findings are hypothesis-generating rather than causal or practice-defining.
SEP 4, 2026 · JOURNAL ARTICLE
Hormone and Metabolic Research
This is a literature review synthesizing evidence on GLP-1 and MC4R agonists for obesity and type 2 diabetes, presenting expert assessment of mechanisms and clinical efficacy rather than reporting original trial data.
SEP 3, 2026 · JOURNAL ARTICLE
Current Medical Research and Opinion
A narrative review synthesizing evidence on pharmacological strategies for type 2 diabetes prevention in obese individuals, grading existing agents by strength of preventive evidence and positioning incretin agonists within the prevention landscape.